Long-term course of binge eating disorder and bulimia nervosa: Relevance for nosology and diagnostic criteria
About this resource
OBJECTIVE: To present the twelve-year outcome of binge eating disorder (BED) in 68 female inpatients compared to bulimia nervosa, purging type (BN-P; N = 196). METHOD: Self and expert ratings focused on the beginning of therapy and the 12-year follow-up. RESULTS: 36 % of BED and 28.2 % of BN-P patients still received an eating disorder diagnosis at follow-up. Differences between groups were small (Eating Disorder Inventory, Structured Inventory for Anorexic and Bulimic Syndromes, Hopkins Symptom Checklist, Beck Depression Inventory). Similar predictors for BED and BN-P were identified. Psychiatric comorbidity was the predominant predictor of poor outcome in both diagnoses. Predictors for BED outcome were body dissatisfaction, sexual abuse, and impulsivity; self-injury predicted BN-P outcome. CONCLUSION: Course, outcome, and mortality were similar for BED and BN-P. Both disorders had psychiatric comorbidity as the main predictor of outcome, and there was a diagnostic shift between BED and BN-P over time, pointing to their nosological proximity. Data are relevant for the formulation of DSM-V and ICD-11 diagnostic criteria.
Prevalence and sociodemographic correlates of DSM-5 eating disorders in the Australian population
Background New DSM-5 diagnostic criteria for eating disorders were published in 2013.Read more
The impact of early shame memories in Binge Eating Disorder: The mediator effect of current body image shame and cognitive fusion.
This study examined the phenomenology of shame experiences from childhood and adolescence in a sample of women with Binge Eating Disorder.Read more
Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: A randomized double-blind placebo-controlled comparison
Cognitive behavioral therapy (CBT) and certain medications have been shown to be effective for binge eating disorder (BED), but no controlled studies have compared psychological and pharmacological therapies.Read more
Lisdexamfetamine dimesylate in binge eating disorder: A placebo controlled trial
OBJECTIVE: To evaluate lisdexamfetamine dimesylate (LDX) in the treatment of binge eating disorder (BED).Read more